Filing Flows › Strata Critical Medical (SRTA) › Takeover & LBO
Is Strata Critical Medical (SRTA) a takeover target?
A leveraged buyout does not work for Strata Critical Medical on its latest figures: the figures a buyout model needs (revenue, EBITDA, the share count and the price) are not all on file. Historically 6.6% of companies with its figures were bought within a year (1.31× the average). Latest signal (2026-10-16): Third Point Urges Strata Critical Medical to Explore a Sale.
Why a leveraged buyout does not fit
The buyout model needs Strata Critical Medical's revenue, EBITDA, share count and share price; not all of them are on file, so it gives no buyout price.
What a takeover could cost
Takeovers in its sector paid a median premium of 40% over the share price before the deal (the middle half 14.7% to 60.2%), according to the 20 merger proxies and tender-offer responses on EDGAR that state a premium.
The odds, from history
Historically 6.6% of companies with its figures were bought within a year (1.31× the average). Its figures put it in decile 9 of 10 (10 = the most likely to be bought). The odds come from a model of every merger proxy, tender-offer response and going-private statement filed on EDGAR since 2011, set against each company's size, margins, debt, cash flow and growth the year before.
Rumors and deal signals
- 2026-10-16 · news · Third Point Urges Strata Critical Medical to Explore a Sale
Strata Critical Medical's latest quarter
Strata Critical Medical, Q3 2026: revenue $74.1M (+50% year over year), operating margin -5.2%, net loss $7.6M, operating cash flow $9.5M. The chart follows the revenue to costs, profit and cash.
Questions
Is Strata Critical Medical being acquired?
The latest signal on file is from 2026-10-16: Third Point Urges Strata Critical Medical to Explore a Sale. A headline is not a deal; Filing Flows lists the news, 8-K filings and 13D filings about a sale.
Could private equity buy Strata Critical Medical?
A leveraged buyout does not work for Strata Critical Medical on its latest figures: the figures a buyout model needs (revenue, EBITDA, the share count and the price) are not all on file. The model gives no buyout price until they are.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.